Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy

BACKGROUND: Integrase strand transfer inhibitors (INSTIs) have been associated with an increased risk for cardiovascular disease (CVD) events. We investigated the impact of starting INSTI-based antiretroviral therapy (ART) on CVD events among treatment-naïve people with human immunodeficiency virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Surial, Bernard, Chammartin, Frédérique, Damas, José, Calmy, Alexandra, Haerry, David, Stöckle, Marcel, Schmid, Patrick, Bernasconi, Enos, Fux, Christoph A, Tarr, Philip E, Günthard, Huldrych F, Wandeler, Gilles, Rauch, Andri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495132/
https://www.ncbi.nlm.nih.gov/pubmed/37157869
http://dx.doi.org/10.1093/cid/ciad286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495132/
https://www.ncbi.nlm.nih.gov/pubmed/37157869
http://dx.doi.org/10.1093/cid/ciad286

Ejemplares similares